medline.ch Respirationstrakt Neoplasie

	Salvage R0 Resection on Post-Recurrence Survival After Pulmonary Metastasectomy for Colorectal Cancer: A Multicenter Retrospective Study. Ann Surg Oncol Hashimoto S, Tominaga T, Shiraishi T, Noda K, Yamashita M, Katayama H, Takamura Y, Mizoguchi S, Obata T, Taniguchi D, Doi R, Shimoyama K, Miyazaki T, Hisanaga M, Ishii M, Ono R, Nakatsukasa T, Kamohara R, Araki M, Sumida Y, Nakamura A, Nonaka T, Matsumoto K. PMID: 42749975 [PubMed - as supplied by publisher]
	mRNA-based therapeutics in lung Cancer: Mechanisms, applications, and translational challenges. J Genet Eng Biotechnol Wehbe I, Tlili A. PMID: 42749398 [PubMed]
	National trends, variation and short-term outcomes in surgery for non-small cell lung cancer in England, 2015-2023: a population-based cohort study using linked national cancer registration and hospital administrative data. BMJ Open Dixon LK, Cook S, Cook A, Thomas J, Boudour J, Chan F, Conibear J, West D, Navani N, Cromwell DA. PMID: 42749376 [PubMed - indexed for MEDLINE]
	Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination TherapyÂ With EGFR Inhibitors. Respirology Sunaga N, Hasegawa Y, Sato M. PMID: 42749289 [PubMed - as supplied by publisher]
	Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer in a Phase 2 Study. J Thorac Oncol Bauer TM, Martini JF, Besse B, Lin CC, Soo RA, Riely GJ, Wang IM, Toffalorio F, Shepard DA, Usari T, Hamilton P, Camidge DR, Kao S, Chiari R, Gadgeel S, Felip E, Shaw AT, Solomon BJ. PMID: 42749050 [PubMed - as supplied by publisher]
	Defining Early Recurrence in Resectable Non-small Cell Lung Cancer Using Post-Recurrence Survival. Lung Naeem W, Khan AA, Rabin EE, Broad S, Denson KL, Casanova T, Basu S, Alex G, Geissen N, Liptay MJ, Seder CW. PMID: 42747627 [PubMed - indexed for MEDLINE]
	Unveiling BRAF Mutations in Non-small Cell Lung Cancer: State of the Art and Future Perspectives. Lung Colombino M, Paliogiannis P, Palomba G, Pisano M, Casula M, Fois AG, Zinellu A, Palmieri G. PMID: 42747511 [PubMed - indexed for MEDLINE]
	Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis. Front Immunol Liang D, Liu Q, Liu M, Li Y. PMID: 42746176 [PubMed - indexed for MEDLINE]
	Associations of derived inflammatory, lipid, and anthropometric indices with CT-detected pulmonary nodules: a hospital-based cross-sectional study with explainable machine learning. Front Endocrinol (Lausanne) Wang M, Zhou Y, Wu B, Liu Y, Luo X, Zhang A. PMID: 42745967 [PubMed - indexed for MEDLINE]
	Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity. 3 Biotech Liu D, He B, Zhou X, Yang Y, Song M, Xu X. PMID: 42745950 [PubMed]
	Clinical inflammatory shifts and peripheral flow-cytometry immune modules across benign pulmonary nodules, adenocarcinoma-spectrum nodules, and overt lung cancer. Front Immunol Rao Y, Gong Q, Li J, Liu N, Miao H, Huang J, Xu S. PMID: 42745767 [PubMed - indexed for MEDLINE]
	Plain language summary of the KRYSTAL-12 study results: adagrasib for non-small cell lung cancer with KRAS(G12C) mutations. Future Oncol Barlesi F, Yao W, Duruisseaux M, Doucet L, Azkárate Martínez A, Gregorc V, Juan-Vidal O, Lu S, De Bondt C, de Marinis F, Linardou H, Kim YC, Jotte R, Felip E, Lo Russo G, Reck M, MichenzIe MF, Yang W, Meade JN, Korytowsky B, Mok TSK, KRYSTAL-12 Investigators. PMID: 42745627 [PubMed - as supplied by publisher]
	Barriers and facilitators to population-based lung cancer screening in Belgium: a qualitative stakeholder analysis in a pre-implementation context. BMC Health Serv Res Michiels L, Duchateau J, Vangilbergen A, Verlies C, Dooms C, Van Hal G, Huys I. PMID: 42745254 [PubMed - indexed for MEDLINE]
	Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS(G12D) mutations: a phase 1 trial. Nat Med Ai X, Song Z, Wu L, Zhou A, Cheng D, Zong H, Wu H, Niu Z, Sun Y, Zhu L, Li Z, Deng Y, Yuan Y, Qu X, Zhao H, Du Y, Li Z, Wang Y, Shen H, Zhu H, Zheng C, Wang S, Cui Z, Tai L, Lu S. PMID: 42745055 [PubMed - indexed for MEDLINE]
	Participant views of case finding for COPD after lung cancer screening: the C FIND COPD study. BMJ Open Respir Res Phillips OR, McKeever TM, Porte J, Almeida PCA, O'Dowd EL, Murray RL, Bolton CE. PMID: 42744412 [PubMed - indexed for MEDLINE]
	Pilot feasibility study to deliver low-dose CT lung cancer screening in Scotland: descriptive findings from the LungScot study. BMJ Open Cavers D, Akram AR, Sage EK, Maclay JD, Cowell GW, Mitchell J, Dickie G, Campbell C, Robb KA, Sullivan F, Murchie P, Neilson A, Steele RJC, van Beek EJR, Weller D. PMID: 42744380 [PubMed - indexed for MEDLINE]
	Long-term exposure to wildfire-related PM(2Â·5) and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study. Lancet Oncol Zhang M, Wisnivesky JP, Qiu M, Danesh Yazdi M, Yin K, Wright RJ, Schwartz JD, Ekenga CC, Wright RO, Wei Y. PMID: 42743939 [PubMed - as supplied by publisher]
	Multi-view attention-based deep learning for benign-malignant classification of pulmonary nodules. PLoS One Zhang L, Zhuo D, Wu X, He Y, Kang G. PMID: 42743330 [PubMed - indexed for MEDLINE]
	A novel one-step multiplex PCR method (OS-MPCR) for efficient NGS library preparation in cancer. PLoS One Feng H, Hu X, Zhang L, Zhang Q, Wang S, Lv B, Zhang Y, Shi D, Zhou P. PMID: 42743120 [PubMed - indexed for MEDLINE]
	Prognostic value of melatonin-related signature genes in lung adenocarcinoma. PLoS One Guo H, Liu L, Lu Y, Ma Y, Ren X, Cui T. PMID: 42743116 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 163129

Seite 1 von 8157



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung